Global variation in prior exposure shapes antibody neutralization profiles of SARS-CoV-2 variants up to BA.2.86
Turner, S.; Amirthalingam, G.; Bailey, D.; Barouch, D. H.; Bewley, K. R.; Brown, K.; Cao, Y. R.; Chan, Y.-W.; Charlton, S.; DOVE consortium, ; Coombes, N. S.; Hallis, B.; Ho, D. D.; Jian, F.; Lasrado, N.; Lassauniere, R.; Lihong, L.; Montefiori, D. C.; Moss, P.; Newman, J.; Parry, H.; Polacek Strandh, C.; Rasmussen, M.; Shao, F.; Shen, X.; Thakur, N.; Thomson, E. C.; Wang, J.; Wang, P.; Wang, Q. C.; Willett, B. J.; Yisimayi, A.; Smith, D. J.
Show abstract
The highly mutated SARS-CoV-2 variant, BA.2.86, and its descendants are now the most frequently sequenced variants of SARS-CoV-2. We analyze antibody neutralization data from eight laboratories from the UK, USA, Denmark, and China, including two datasets assessing the effect of XBB.1.5 vaccines, to determine the effect of infection and vaccination history on neutralization of variants up to and including BA.2.86, and produce antibody landscapes to describe these neutralization profiles. We find evidence for lower levels of immune imprinting on pre-Omicron variants in sera collected from Denmark and China, which may be explained by lower levels of circulation of the ancestral variant in these countries, and the use of an inactivated virus vaccine in China.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Structure selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern 96%
- Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection 96%
- A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 delta variant 95%
Similar papers in this journal
Similar papers in this journal
- Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin 96%
- Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein after infection and/or vaccination 95%
- Functional characterization and lineage analysis of broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics 95%
Similar papers in this journal
- Systematical assessment of the impact of single spike mutations of SARS-CoV-2 Omicron sub-variants on the neutralization capacity of post-vaccination sera 97%
- A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants 95%
- Memory B cell and humoral responses elicited by Sputnik V in naïve and COVID-19-recovered vaccine recipients 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.